Research
Rigorous, shared and reproducible science — the only credible route from insight to earlier answers.
How RBD-IBI is organised, what it exists to do, and who it works for.
Rare bone diseases affect small numbers of people in any one place, which is why progress has historically been slow. RBD-IBI is designed to make the field measurable — through quantitative imaging biomarkers that can be compared across centres, studies and countries.
Designed to unite shared pathology, shared imaging and shared data, common protocols and open evidence will help discoveries in one country benefit people everywhere — equally and openly.
The identity that holds RBD-IBI together — an independent, international, clinician-led and platform-independent initiative advancing Imaging Biomarker Science for Rare Bone Diseases.
Rigorous, shared and reproducible science — the only credible route from insight to earlier answers.
Built for people living with rare bone diseases and the families who care for them.
Objective measurement that gets people answers sooner — earlier diagnosis, earlier monitoring, earlier evaluation of therapies.
The Charter, mission, vision and principles below govern how the Initiative works — and who it answers to.
Research that is registered, reproducible and honestly reported — evidence you can trust.
Open methods and shared credit across the network — science moves faster together.
The same science and opportunity for every country, not only the well-resourced.
Research designed with patients and families — not merely about them.
Ambition is designed to be delivered in phases — each one building openly on the last.